Veracyte Inc (VCYT)
39.59
+0.65
(+1.67%)
USD |
NASDAQ |
Nov 22, 16:00
39.51
-0.08
(-0.20%)
After-Hours: 20:00
Veracyte Price: 39.59 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 38.79 | 39.75 | 38.13 | 39.59 | 693257.0 |
| Nov 21, 2024 | 39.38 | 39.81 | 38.73 | 38.94 | 634453.0 |
| Nov 20, 2024 | 39.16 | 39.80 | 38.61 | 39.20 | 632021.0 |
| Nov 19, 2024 | 36.40 | 39.19 | 36.38 | 39.15 | 850157.0 |
| Nov 18, 2024 | 36.05 | 37.30 | 35.73 | 36.71 | 804488.0 |
| Nov 15, 2024 | 37.76 | 37.76 | 35.37 | 35.94 | 1.627M |
| Nov 14, 2024 | 39.53 | 39.98 | 36.80 | 37.04 | 877283.0 |
| Nov 13, 2024 | 38.69 | 39.70 | 38.40 | 39.53 | 1.143M |
| Nov 12, 2024 | 38.52 | 38.78 | 37.92 | 38.24 | 873833.0 |
| Nov 11, 2024 | 36.94 | 38.93 | 36.94 | 38.89 | 1.050M |
| Nov 08, 2024 | 37.15 | 37.84 | 36.35 | 36.48 | 902733.0 |
| Nov 07, 2024 | 39.70 | 41.43 | 37.28 | 37.34 | 1.935M |
| Nov 06, 2024 | 36.77 | 37.40 | 35.89 | 36.59 | 1.198M |
| Nov 05, 2024 | 34.77 | 36.26 | 34.41 | 35.93 | 887982.0 |
| Nov 04, 2024 | 34.22 | 35.03 | 33.56 | 34.98 | 686664.0 |
| Nov 01, 2024 | 33.96 | 34.36 | 33.61 | 34.31 | 553888.0 |
| Oct 31, 2024 | 34.75 | 34.75 | 33.62 | 33.74 | 803075.0 |
| Oct 30, 2024 | 33.93 | 35.29 | 33.76 | 35.00 | 449261.0 |
| Oct 29, 2024 | 33.77 | 34.46 | 33.62 | 34.38 | 338660.0 |
| Oct 28, 2024 | 33.27 | 34.36 | 33.13 | 34.12 | 815202.0 |
| Oct 25, 2024 | 32.95 | 33.62 | 32.84 | 33.03 | 473289.0 |
| Oct 24, 2024 | 32.82 | 33.22 | 32.29 | 32.78 | 536176.0 |
| Oct 23, 2024 | 32.42 | 32.47 | 31.93 | 32.45 | 625596.0 |
| Oct 22, 2024 | 32.87 | 32.87 | 32.21 | 32.60 | 471595.0 |
| Oct 21, 2024 | 34.38 | 34.44 | 33.06 | 33.12 | 585505.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
15.31
Minimum
Oct 20 2022
81.38
Maximum
Feb 09 2021
30.79
Average
26.70
Median
Price Benchmarks
| Fonar Corp | 16.44 |
| XWELL Inc | 1.50 |
| ProPhase Labs Inc | 0.7689 |
| Applied DNA Sciences Inc | 0.155 |
| OncoCyte Corp | 2.71 |
Price Related Metrics
| PS Ratio | 7.062 |
| Price to Book Value | 2.609 |
| Price to Free Cash Flow | 53.18 |
| Earnings Yield | -0.38% |
| Market Cap | 3.068B |
| Operating PE Ratio | 273.16 |
| Normalized PE Ratio | 165.45 |